PDUFA REAUTHORIZATION LINKED TO FDA MANAGEMENT CHANGES BY REP. BARTON; USER FEE BILL HINGES ON APPROPRIATIONS PROCESS, SAYS HEALTH SUBCMTE. CHAIRMAN BILIRAKIS
Executive Summary
House Commerce/Oversight Subcommittee Chairman Barton (R-Tex.) is continuing to push for management changes at FDA as a higher priority than user fee reauthorization.